ControlRad announces FDA clearance and closing of series C financing
Summary
ControlRad received FDA 510(k) clearance for its Trace technology on OEC 9900 Mobile C-arms. The company says the clearance expands access to its radiation-reduction solution for more patients and clinical staff. ControlRad also closed a Series C financing round led by existing investor Questa Capital, with Windham Ventures joining the investor group. The company plans to use the capital to expand commercial reach and accelerate adoption of its retrofit technology.
Funding
Amount
None
Total raised
Date
September 15, 2020
Announcement date
Investors
Questa Capital
Lead investors
Company
controlrad.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected